Placental Stem Cell Therapy Market, By Therapy Type, By Cell Type, By End-user, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

The Placental Stem Cell Therapy Market size was valued at US$ 455 Million in 2024, expanding at a CAGR of 18.5% from 2025 to 2032.

Placental Stem Cell Therapy leverages placental-derived stem cells to treat neurological and other disorders. A key market trend is the growing emphasis on regenerative medicine, highlighting the ability of stem cells to repair or replace damaged neurons and address unmet medical needs in neurological conditions. Advances in biotechnology and stem cell research are accelerating market growth. However, regulatory challenges remain a significant barrier, as stringent approval processes can delay market entry and increase development costs. Additionally, the high cost of therapies limits accessibility, constraining patient reach and overall market expansion.

Placental Stem Cell Therapy Market- Market Dynamics

Technological Advances and Innovative Research Drive Market Growth

Technological advancements and innovative research are critical drivers of growth in the placental stem cell therapy market. Cutting-edge technologies improve the isolation, processing, and application of stem cells, thereby increasing treatment efficiency and safety. For instance, in November 2023, researchers from the Critical Analytics for Manufacturing Personalized Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), in collaboration with ASTAR's Bioprocessing Technology Institute (BTI) and the National University Health System (NUHS), developed a technology to extract mesenchymal stem cells (MSCs) directly from pure bone marrow aspirate, streamlining. This demonstrates how research breakthroughs drive market growth.

Placental Stem Cell Therapy Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Therapy Type, Cell Type, End-user, Application, and Region.

The therapy type segment is primarily divided into two groups Allogeneic Therapy and Autologous Therapy. Allogeneic therapies are an important segment due to their "off-the-shelf" availability. These donor-derived cell products can be cryopreserved and used right away, making them ideal for emergency neurological care where prompt intervention is required. This operational advantage eliminates the time and expense associated with patient-specific (autologous) cell harvesting. This shift is also being supported by global regulatory focuses; in 2023, the World Health Organization endorsed updated global principles for human cell and tissue therapies, strengthening quality, traceability, and safety standards across member states and allowing for broader deployment of allogeneic cell products in clinical settings. Furthermore, national regenerative-medicine policies are accelerating scale-up; for example, Japan's PMDA approved over 20 new cell- and tissue-based therapy trials between 2022 and 2024, many of which used allogeneic cell banking systems to reduce manufacturing time. These clinical and regulatory factors place allogeneic placental stem cell therapies in a strategic position to contribute to market growth.

Based on End user segment, Academic and research institutions play critical roles in the development of placental stem cell therapies. Their work frequently focuses on understanding the biology, safety, and therapeutic potential of placental-derived mesenchymal stromal cells (MSCs), as well as developing good manufacturing practices (GMP) protocols and preclinical efficacy in neurological models. A 2024 study published in Frontiers in Bioscience by a university-affiliated research center found that human placenta-derived MSCs significantly improved neurological outcomes in a rat model of hypoxic-ischemic encephalopathy by reducing inflammation and neuronal apoptosis.

Placental Stem Cell Therapy Market- Geographical Insights

North America has a significant market share for placental stem cell therapy. Adoption in the region is being driven by a growing awareness of placental stem cells' therapeutic potential for neurological conditions. Increased patient interest in alternative treatments for neurological disorders, combined with advances in therapy development, is driving market growth. Collaborations among academic institutions, healthcare providers, and biotechnology companies have facilitated the establishment of specialized facilities, increased accessibility and allowing clinical applications of placental stem cell therapies for neurological conditions.

United States Placental Stem Cell Therapy Market- Country Insights

The United States plays a pivotal role in generating revenue within the placental stem cell therapy market for neurological disorders, driven by the increasing prevalence of age-associated conditions such as Alzheimer's and Parkinson's disease. By 2050, it is projected that 13 million Americans aged 65 and older will be living with Alzheimer's, up from approximately 7.2 million in 2025. In 2024, nearly 12 million Americans provided unpaid care for individuals suffering from dementia, highlighting the urgent need for effective therapies. Additionally, nearly one million Americans are affected by Parkinson's disease, with risk increasing sharply with age. These statistics underscore the rising demand for innovative treatment options, positioning placental stem cell therapies as a significant therapeutic approach for managing neurological disorders in the U.S.

Placental Stem Cell Therapy Market- Competitive Landscape:

The placental stem cell therapy market is moderately concentrated, with a few key players driving innovation and expanding their global presence. Thermo Fisher Scientific, Inc., Cell Applications, Inc., Bio-Techne, and Cellular Engineering Technologies are among the leading companies that specialize in developing advanced stem cell therapies for neurological and other degenerative disorders. These companies compete by developing new cell isolation, storage, and delivery technologies that improve safety, efficacy, and patient outcomes. For example, Pluristem Therapeutics announced a strategic partnership with a biopharmaceutical company in the United States in February 2024 to advance clinical trials of placental-derived mesenchymal stem cells for ischemic stroke treatment, and to enter the market quickly. Continuous R&D investments, collaborations with academic institutions, and regulatory approvals that facilitate product commercialization all help to shape market competition. To meet the increasing global demand for regenerative therapies, expansion strategies include strengthening manufacturing capabilities and entering emerging markets.

Recent Developments:

In December 2024, Mesoblast Limited has announced that Ryoncil (remestemcel-L) has received FDA approval as the first mesenchymal stromal cell (MSC) therapy in the United States. Ryoncil is now the only MSC therapy approved in the United States, as well as the first treatment for steroid-resistant acute graft-versus-host disease (SR-aGvHD) in children as young as two months old, including adolescents and teenagers. Dr. Joanne Kurtzberg, a leading transplant physician at Duke University Medical Center, emphasized the importance of this approval, stating that Ryoncil provides a life-saving option for children with this severe condition, giving hope to both patients and their families.

In October, 2024, Aspen Neuroscience, Inc. has announced the expansion of its San Diego operations with a new 22,000 square foot facility dedicated to the GMP manufacturing of induced pluripotent stem cell (iPSC)-based therapies. This facility, located near the company's headquarters, will manufacture ANPD001, an iPSC-derived cell therapy for Parkinson's disease, as part of the ASPIRO trial. The expansion includes ISO-certified manufacturing suites, quality control labs, and more room for future growth and automation. Aspen is also working to industrialize autologous cell therapy manufacturing to improve throughput and streamline production processes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLACENTAL STEM CELL THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific, Inc
Cell Applications, Inc.
Bio-Techne
Cellular Engineering Technologies
AlloSource
STEMCELL Technologies, Inc.
PromoCell GmbH
Takara Holdings, Inc.
Lonza
Merck KGaA
Sartorius AG (CellGenix GmbH)
ATCC
AcceGen
Mesoblast Ltd
Others

GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

Allogeneic Therapy
Autologous Therapy

GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

Mesenchymal Stem Cells (MSCs)
Endothelial Progenitor Cells (EPCs)
Umbilical-Derived MSCs
Hematopoietic Stem Cells (HSCs)
Placental-Derived MSCs
Mixed/Co-Culture Stem Cells

GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals & Specialty Clinics
Research & Academic Institutes
Biopharmaceutical Companies
Contract Research Organizations (CROs)

GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Hematologic Malignancies and Disorders
Metabolic Disorders
Neurological Disorders
Congenital Immunodeficiency Disorders
Others

GLOBAL PLACENTAL STEM CELL THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5748

1. Placental Stem Cell Therapy Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Placental Stem Cell Therapy Market Snippet by Therapy Type
- 2.1.2. Placental Stem Cell Therapy Market Snippet by Cell Type
- 2.1.3. Placental Stem Cell Therapy Market Snippet by End-user
- 2.1.4. Placental Stem Cell Therapy Market Snippet by Application
- 2.1.5. Placental Stem Cell Therapy Market Snippet by Country
- 2.1.6. Placental Stem Cell Therapy Market Snippet by Region
2.2. Competitive Insights

3. Placental Stem Cell Therapy Key Market Trends

3.1. Placental Stem Cell Therapy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Placental Stem Cell Therapy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Placental Stem Cell Therapy Market Opportunities
3.4. Placental Stem Cell Therapy Market Future Trends

4. Placental Stem Cell Therapy Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Placental Stem Cell Therapy Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Placental Stem Cell Therapy Market Landscape

6.1. Placental Stem Cell Therapy Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Placental Stem Cell Therapy Market - By Therapy Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapy Type, 2024 & 2032 (%)
- 7.1.2. Allogeneic Therapy
- 7.1.3. Autologous Therapy

8. Placental Stem Cell Therapy Market - By Cell Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Cell Type, 2024 & 2032 (%)
- 8.1.2. Mesenchymal Stem Cells (MSCs)
- 8.1.3. Endothelial Progenitor Cells (EPCs)
- 8.1.4. Umbilical-Derived MSCs
- 8.1.5. Hematopoietic Stem Cells (HSCs)
- 8.1.6. Placental-Derived MSCs
- 8.1.7. Mixed/Co-Culture Stem Cells

9. Placental Stem Cell Therapy Market - By End-user

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
- 9.1.2. Hospitals & Specialty Clinics
- 9.1.3. Research & Academic Institutes
- 9.1.4. Biopharmaceutical Companies
- 9.1.5. Contract Research Organizations (CROs)

10. Placental Stem Cell Therapy Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Cell Type, 2024 & 2032 (%)
- 10.1.2. Hematologic Malignancies and Disorders
- 10.1.3. Metabolic Disorders
- 10.1.4. Neurological Disorders
- 10.1.5. Congenital Immunodeficiency Disorders
- 10.1.6. Others

11. Placental Stem Cell Therapy Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Placental Stem Cell Therapy Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Placental Stem Cell Therapy Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Placental Stem Cell Therapy Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Placental Stem Cell Therapy Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Placental Stem Cell Therapy Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Placental Stem Cell Therapy Industry

12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Thermo Fisher Scientific, Inc
- 12.2.2. Cell Applications, Inc.
- 12.2.3. Bio-Techne
- 12.2.4. Cellular Engineering Technologies
- 12.2.5. AlloSource
- 12.2.6. STEMCELL Technologies, Inc.
- 12.2.7. PromoCell GmbH
- 12.2.8. Takara Holdings, Inc.
- 12.2.9. Lonza
- 12.2.10. Merck KGaA
- 12.2.11. Sartorius AG (CellGenix GmbH)
- 12.2.12. ATCC
- 12.2.13. AcceGen
- 12.2.14. Mesoblast Ltd
- 12.2.15. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us